Abstract
Plasma membrane monoamine transporter (PMAT) is a new polyspecific transporter that interacts with a wide range of structurally diverse organic cations. To map the physicochemical descriptors of cationic compounds that allow interaction with PMAT, we systematically analyzed the interactions between PMAT and three series of structural analogs of known organic cation substrates including phenylalkylamines, n-tetraalkylammonium (n-TAA) compounds, and β-carbolines. Our results showed that phenylalkylamines with a distance between the aromatic ring and the positively charged amine nitrogen atom of ∼6.4 Å confer optimal interactions with PMAT, whereas studies with n-TAA compounds revealed an excellent correlation between IC50 values and hydrophobicity. The five β-carbolines that we tested, which possess a pyridinium-like structure and are structurally related to the neurotoxin 1-methyl-4-phenylpyridinium, inhibited PMAT with high affinity (IC50 values of 39.1–65.5 μM). Cytotoxicity analysis further showed that cells expressing PMAT are 14- to 15-fold more sensitive to harmalan and norharmanium, suggesting that these two β-carbolines are also transportable substrates of PMAT. We then used computer-aided modeling to generate qualitative and quantitative three-dimensional pharmacophore models on the basis of 23 previously reported and currently identified PMAT inhibitors and noninhibitors. These models are characterized by a hydrogen bond donor and two to three hydrophobic features with distances between the hydrogen bond donor and hydrophobic features ranging between 5.20 and 7.02 Å. The consistency between the mapping results and observed PMAT affinity of a set of test compounds indicates that the models performed well in inhibitor prediction and could be useful for future virtual screening of new PMAT inhibitors.
Footnotes
This work was supported by the National Institutes of Health National Institute of General Medicine Sciences [Grants GM066233, GM066233-07S1].
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
doi:10.1124/jpet.111.184036.
-
ABBREVIATIONS:
- OCT
- organic cation transporter
- SLC
- solute carrier family
- PMAT
- plasma membrane monoamine transporter
- TM
- transmembrane domain
- MPP+
- 1-methyl-4-phenylpyridinium
- n-TAA
- n-tetraalkylammonium
- TMA
- tetramethylammonium
- TPrA
- tetrapropylammonium
- TBA
- tetrabutylammonium
- TPeA
- tetrampentylammonium
- THA
- tetrahexylammonium
- TbuMA
- tributylmethylammonium
- MDCK
- Madin-Darby canine kidney
- HEK
- human embryonic kidney
- KRH
- Krebs-Ringer Henseleit
- MTT
- 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
- DS
- Discovery Studio
- 3D
- three-dimensional
- Ar
- aromatic ring
- N
- positively charged amine nitrogen atom
- PAH
- p-aminohippuric acid.
- Received May 15, 2011.
- Accepted August 3, 2011.
- Copyright © 2011 by The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|